Development and testing of second generation extracorporeal shock-wave lithotriptor.

Area of Science:

• Biomedical Engineering
• Medical Devices
• Urology

Background:

• Extracorporeal shock-wave lithotripsy (ESWL) is a common procedure for kidney stone treatment.
• Advancements in ESWL technology aim to improve stone localization and fragmentation efficiency.
• The Northgate SD-3 represents a second-generation ESWL device with integrated guidance systems.

Purpose of the Study:

• To evaluate the performance of the Northgate SD-3 extracorporeal shock-wave lithotriptor.
• To compare its pressure wave characteristics and energy output with a established device (Dornier HM-3).
• To assess the accuracy of its ultrasound-guided computer-assisted localization system and its calculus fragmentation efficacy.

Main Methods:

• Comparative analysis of pressure wave characteristics and energy output between the SD-3 and HM-3 lithotriptors.
• Testing the ultrasound unit's ability to identify radiolucent calculi and small fragments (2-3 mm).
• Evaluation of the computer-assisted aiming system's accuracy (within 1 mm) and calculus fragmentation rates in an animal model.

Main Results:

• The SD-3 demonstrated comparable pressure wave characteristics and energy output to the Dornier HM-3.
• The ultrasound system successfully identified radiolucent calculi and fragments as small as 2-3 mm.
• The computer-assisted aiming system achieved accuracy within 1 mm.
• Initial calculus fragmentation rate was 80%, increasing to 87.5% after modifications enhancing energy output.

Conclusions:

• The Northgate SD-3 is a capable second-generation lithotriptor with effective ultrasound-guided localization and fragmentation.
• Its performance is comparable to established systems, with potential for improvement through energy output optimization.
• The device shows promise for clinical application in kidney stone treatment.